Abstract
Regulatory T cells (Tregs) are specific subtype of T cells that play a central role in sustaining self‐antigen tolerance and restricting inflammatory tissue damage. More recently, additional direct functions of Tregs in mammalian tissue repair have emerged, but the regenerative potential of Tregs in non‐mammalian vertebrates has not been explored despite the latter possessing a highly developed adaptive immune system. Why complex organs such as the caudal fin, heart, brain, spinal cord and retina regenerate in certain non‐mammalian vertebrates, but not in mammals, is an interesting but unresolved question in the field of regenerative biology. Inflammation has traditionally been thought to be an impediment to regeneration due to the formation of scars. Regenerative decline in higher organisms has been speculated to be the evolutionary advent of adaptive immunity. Recent studies, however, have shown that the innate inflammatory response in non‐mammalian organisms is required for organ regeneration. It has also been found that highly advanced adaptive immunity is no longer incompatible with regeneration and for that, Tregs are important. Zebrafish regulatory T cells (zTregs) migrate rapidly to the injury site in damaged organs, where they facilitate the proliferation of regeneration precursor cells by generating tissue‐specific regenerative factors by a process distinct from the canonical anti‐inflammatory pathway. We review both reparative and proregenerative roles of Tregs in mammals and zebrafish, respectively, and also give an overview of the forkhead box protein 3 (FoxP3) ‐dependent immunosuppressive function of Tregs in zebrafish, which makes it a useful model organism for future Treg biology and research.
Keywords: immunosuppression, inflammation, proregenerative factor, tissue repair and regeneration, Tregs , zebrafish
In mammals, Treg s modulate inflammation and lead to tissue repair through inhibition of neutrophil and inflammatory macrophage, and exerting immunosupressive role by releasing anti‐inflammatory cytokines. In addition to immunosuppressive role, zTreg s secerete proregenerative factors in injury niche for successful tissue regeneration. zTreg s display unique organ‐specific proregenerative factor secretion ability to induce tissue resident progenitor cell proliferation during regeneration.
INTRODUCTION
Regulatory T cells (Tregs) represent around 5%–10% of the T cell population in peripheral circulation and are important mediators of peripheral self‐ and non‐self antigenic tolerance [1]. This immunoregulatory control of Tregs is achieved by direct cell‐to‐cell interaction via the production of anti‐inflammatory cytokines that inhibit innate immune cells, the functioning of antigen‐presenting cells (APCs) as well as the functioning of the B cells, CD4+ or CD8+ effector T (Teff) cells [2]. Although Tregs are not the only immune cells responsible for immune suppression, they are considered to play the most important role in case of immunosuppression.
Tregs belong to a subset of CD4+ T cells, are of two main types – natural Treg and adaptive (or induced) Treg. Natural Tregs characteristically express some cell surface markers, which include interleukin (IL)‐2 receptor alpha chain (CD25) and cytotoxic T lymphocyte antigen‐4 (CTLA‐4). Forkhead box P3 (FoxP3) transcription factor is another marker that is expressed in the nucleus of natural Tregs. They secrete IL‐10 and transforming growth factor (TGF)‐β, preventing effector T cells (Teff) from proliferation. They suppress the release of proinflammatory cytokines such as interferon (IFN)‐γ and tumor necrosis factor (TNF)‐α in response to mitogenic and antigenic stimulation. Conversely, adaptive Tregs are FoxP3+ antigen‐specific immunosuppressors that are generated from CD4+ T cells stimulated with TGF‐β and IL‐10, and act identically to normal Tregs [3, 4, 5, 6]. FoxP3 expression is critical for Tregs to act as immunosuppressive cells [7, 8]. There are several signaling cascades that are responsible for Treg production in addition to FoxP3, which is the master regulator of Treg. TGF‐β‐SMAD signaling also plays an essential role in developing Treg from naive CD4+ T cells [9].
FoxP3 regulation of Treg is crucial for the resolution of inflammation. In humans, a FoxP3 gene mutation that obstructs the FoxP3 function leads to a rare human disease – immunodysregulation polyendocrinopathy enteropathy X‐linked (IPEX) – in which persistent inflammatory conditions including increased cytokine synthesis, are among the main symptoms [6, 10].
Tregs are known to suppress a variety of immune cells, including B cells, natural killer (NK) cells, natural killer T (NKT) cells and often CD4+ or CD8+ T cells. The suppression of conventional CD4+ T cells involves a number of mechanisms. Depending on the site of suppression, the activation states of the target cell and the Treg itself, different pathways exist and participate [11]. Tregs rapidly suppress T cell receptor (TCR)‐induced signaling pathways such as Ca2+, nuclear factor of activated T cells (NFAT) and nuclear factor kappa B (NF‐κB) signaling in conventional T cells (Tconv). In order to perform their suppressive role on target cells, they also produce immunosuppressive molecules such as adenosine and other immunosuppressive cytokines (IL‐10, TGF‐β, IL‐35) [11, 12]. Human Tregs have been found to express the serine protease granzyme‐A, which induces the destruction of effector cells through a perforin‐dependent pathway [13]. Tregs also suppress T cells partially by down‐regulating co‐stimulatory molecules such as CD80 and CD86 on APCs via CTLA‐4 [8, 12, 14].
REGULATORY T CELLS IN TISSUE REPAIR AND REGENERATION
Tregs have also been linked to reducing tissue damage in addition to securing immunological tolerance to chronic exposures of ‘self’ and ‘non‐self’ antigens [9, 15]. Tissue repair may be aided by Tregs in addition to the reduction of tissue damage by suppressing inflammatory response after infection [15]. Treg‐mediated tissue repair is induced by suppressing the production of proinflammatory chemokines, endothelial cell activation, and proinflammatory responses of innate and adaptive immune cells [16]. Tregs are found not only in secondary lymphoid organs but also in other non‐lymphoid bodies that quickly recruit circulatory Tregs , while resident Tregs expand in response to tissue damage or injury [17]. Therefore, through the development of mediators on parenchymal cells, Tregs probably play a direct role in tissue repair.
Infiltrating Tregs influence tissue‐resident stem cell proliferation and differentiation following damage in several mouse tissues (e.g. skeletal muscle, lung epithelium and skin). In a dystrophic mouse model, Treg depletion during the repair phase increased the proinflammatory infiltrate and hindered muscle repair, while therapies that increased or decreased Treg activities reduced or improved muscle damage, respectively [18]. According to researchers, muscle Tregs secrete the growth factor Amphiregulin, which directly affects muscle satellite cells in vitro and enhances in vivo muscle repair [18]. Another study found that after cardiotoxin (CTX) injury in mice, a specific CD4+CD25+FoxP3+ population of T cells have been engaged in the repair process of skeletal muscles, which regulates the functioning of skeletal muscle precursor cells in addition to their well‐established role as immune system regulators [19]. In another study, Arpaia et al. demonstrated that Tregs may directly exert tissue repair ability, at least to some extent, through the synthesis of amphiregulin utilizing influenza lung infection in mice as a model of pathogen‐induced inflammation and tissue damage [15]. In the skin of adult mice, a subgroup of Treg releases the epidermal growth factor receptor (EGFR) to promote wound healing [20]. Another research study of transcriptional and phenotypical profiling of Tregs and hair follicular stem cells conducted by Ali et al. supported this repairing role of Treg, which showed that skin‐resident Tregs exclusively express Jagged 1, a member of the Notch family of ligands which, in turn, promotes the activity of hair follicle‐stimulating cells (HFSCs) [21]. Recently, mature T lymphocytes with Treg‐like attributes have been recognized using the FoxP3 orthologue as a marker in zebrafish, and these cells have been found to play a key role in immunoregulation [22]. These findings show that Tregs have a distinct protective role in tissue damage, repair and maintenance, but this function is triggered in response to signals that are distinct from those that activate their immune‐suppressing capability.
REGULATORY T CELLS AS AN INFLAMMATORY MODULATOR IN TISSUE INJURY NICHE
Tregs have also shown that they can regulate both innate as well as adaptive immune systems to facilitate tissue repair by inflammatory modulation. A cascade of immune processes is activated before a new tissue forms post‐injury and Tregs are involved in all these different steps. Tregs can impede neutrophil extravasation through IL‐10 and thus neutralize inflammatory cytokine secretion (e.g. IL‐6, IFN‐γ, TNF‐α and IL‐1β) at the beginning of inflammation [23]. Further, Tregs are capable of facilitating neutrophil apoptosis and induce macrophages for the phagocytic clearance of dead neutrophils [17]. Tregs also release several anti‐inflammatory cytokines (e.g. IL‐4, IL‐10, IL‐13), which impair monocyte activity and survival while also stimulating the polarization of macrophages into an anti‐inflammatory phenotype (M2) [24]. In addition, Tregs naturally restrict CD4+ and CD8+ T cell‐mediated inflammation through the production of IL‐10, TGF‐β and IL‐35 [25, 26]. As a whole, these Treg‐mediated processes lead to tissue repair through the inhibition of neutrophils and inflammatory macrophages and also by CD4+ and CD8+ T cell involvement.
In skeletal muscle repair, IL‐33 assists in recruiting Tregs to the injured site which inhibits inflammation caused by M1 macrophages, promoting muscle repair [27]. In the case of cardiac injury, activated CD4+CD25+ T cell infiltration has been found within the infarcted and distant regions of the myocardium in patients with myocardial infarction (MI) [28]. Through CD39 expression, which promotes extracellular nucleotide degradation to form adenosine, in vitro‐activated Tregs reduce myocardial damage [29]. Therefore, in the case of cardiac injury, Tregs can act through CD39‐mediated adenosine formation [29]. Tregs also enhance post‐MI healing by modulating monocytes and macrophages. Following MI, decreased cardiac activity due to enhanced M1 macrophage invasion and marked left ventricular dilation were observed in cases of Treg depletion in FoxP3DTR mice or anti‐CD25 monoclonal antibody (mAb) treatment [30]. Conversely, superagonistic anti‐CD28 mAb application preferentially activates Treg, leading to higher Treg invasion into the infracted myocardium after MI, induces macrophages in the repairing myocardium to adopt the M2 phenotype and also reduces ventricular ruptures, resulting in improved survival [30]. According to another report, CCR5 knock‐out mice exhibit disrupted Treg infiltration as well as inappropriate remodeling and cardiac dysfunction after MI [31]. Therefore, inflammation, extensive matrix depletion and adverse remodeling after MI are suppressed as a result of CCR5‐mediated Treg recruitment [31].
Tregs suppress the inflammatory activity of M1 macrophage in the lungs and promote the differentiation of impaired type 2 alveolar epithelial cells (AECII) into type 1 alveolar epithelial cells (AECI), and this step is mediated by binding of CD103 ligand to E‐cadherin receptor [32]. Tregs could also stimulate the differentiation of progenitor bronchioalveolar stem cells (BASC) into AECII cells [33]. At the same time, Tregs act via C‐X‐C motif chemokine ligand 12 (CXCL12) to prevent the recruitment proliferation of fibrocytes and prevent fibrosis [33]. Tregs are likely to be recruited in bone repair through C‐C motif chemokine ligand 22 (CCL22), which is used to induce the differentiation of the osteoblast progenitors by inhibiting T helper type 1 (Th1) and M1 macrophages [34].
In the central nervous system (CNS), IL‐33 recruits Tregs to perform a reparative function by promoting M2 macrophage polarization to aid remyelination and oligodendrocyte differentiation [35]. Also, CCN3 promotes myelination and the differentiation of oligodendrocyte progenitor cells in vitro and ex vivo [36]. According to another study, while mouse Tregs invade the CNS minimally they are insufficient to encourage regeneration despite having a strong immunomodulatory impact [37].
ZEBRAFISH REGULATORY T CELLS (zTregs) AND THEIR ROLE IN COMPLEX TISSUE REGENERATION
Unlike mammals, the zebrafish genome has two FOXP3 orthologs, foxp3a and foxp3b, which share the same functional domains as mammalian FoxP3 and may serve a redundant role in Treg formation and its activity [22, 38, 39]. However, although foxp3a embryonic expression rises as T cells mature, foxp3b expression remains substantially constant throughout development in zebrafish [22], suggesting that zebrafish foxp3a is the most probable homolog of mammalian FOXP3. An interesting study [38] first described the Foxp3 function in zebrafish when they were observed through a series of biochemical investigations showing that zebrafish Foxp3a (termed ‘zFoxp3’), like mammalian FOXP3, may have an immunomodulatory role in zebrafish and that FOXP3 involvement in immunosuppressive mechanisms is evolutionarily conserved in non‐mammalian vertebrates. The in vivo function of zebrafish foxp3a has also confirmed an immunomodulatory role in homeostasis by creating a zebrafish mutant with loss‐of‐function foxp3a alleles by using transcription activator‐like effector nucleases (TALEN) [22, 39]. Further, It has been discovered that foxp3a, a zebrafish ortholog of the mammalian FOXP3 gene, mainly defines a fraction of T cells with the conserved gene expression profile of mammalian Tregs [40].
Following tissue injury, the regeneration competent animals require the proliferation of tissue‐resident precursor cells for successful regeneration. Zebrafish regenerative biology is an open area of thorough investigation and the credits for injury‐induced regeneration are attributed to the neural stem cells (ependymo‐radial glial cells) in the spinal cord [41, 42], cardiomyocytes in the heart [43, 44] and Müller glia in the retina [45, 46]. Zebrafish are armoured with both an innate and adaptive immune system akin to mammals and exhibit nearly all types of immune cells [47]. Components of the innate immune system play a crucial role in injury‐induced regenerative responses in the non‐mammalian system and have been thoroughly investigated in multiple organ systems such as brain, limb, caudal fin, heart and retina [48]. Later findings not only challenged the popular dogma that adaptive immunity is incompatible with regeneration, but also confirmed the pivotal roles played by one species of T lymphocyte towards a proregenerative direction. The advent of zTregs in the context of zebrafish regeneration has marked a major paradigm shift in our understanding of existing regenerative immunology.
Tregs are known to exert immunosuppressive roles, but recent studies reveal their regenerative potential in the zebrafish model system. Following a transection injury [42, 49] in zTreg cell‐depleted spinal cords, the rostral and caudal stumps remain disconnected and the locomotor activity also fails to become restored up to a time‐point by which zebrafish can regain their pre‐injury swimming performance. Additionally, clear evidence in favor of the co‐presence of Foxp3a‐expressing zTreg and SRY‐box transcription factor 2 (Sox2) and proliferating cell nuclear antigen (PCNA)‐expressing proliferating neural progenitor cells was found. Post‐injury depletion of zTreg leads to the reduction of Sox2+ neural progenitors at 7 days post injury (dpi) spinal cord and HuC/D+ newly born neurons [40]. Taken together, these findings show us the pivotal role played by zTreg in the proliferation of neural progenitor cells by secreting neurogenic factors such as neurotrophin‐3 (Ntf3), glial cell‐derived neurotrophic factor‐a (Gdnfa) and nerve growth factor beta (Ngfb) in the injury‐induced spinal cord, and thus facilitate spinal cord regeneration in zebrafish [40].
The emergence of proregenerative roles of zTreg has expanded our knowledge of retinal regeneration [45, 46, 50, 51, 52, 53, 54, 55]. Following a poke injury in zTreg cell‐depleted zebrafish retina, the layered structure remains highly disorganized [40]. The role of zTreg in the proliferation of precursor cells has been further confirmed by the presence of foxp3a expressing zTreg in the vicinity of PCNA+ proliferating Müller glia [56]. Depletion of zTreg after a retinal injury leads to a significant reduction in the Müller glia proliferation in the damaged retina [40]. zTregs also produce several growth factors in the damaged retina, which include insulin‐like growth factor 1 (Igf1), heparin‐binding EGF‐like growth factor a (Hb‐egfa), epidermal growth factor (Egf) and platelet‐derived growth factor alpha polypeptide a (Pdgfaa). In the injury‐induced retina the up‐regulation of Igf1 is marked significantly, making it the most important zTreg‐derived Müller glia‐inducing growth factor [40].
Similar to the spinal cord and retinal regeneration, cardiac regeneration [43, 44, 57, 58] in zebrafish is also aided by its Tregs. In regenerating hearts, zebrafish Tregs are seen near or in direct contact with the proliferating cardiomyocytes, indicating a paracrine role in myocardial regeneration. It is evident from some findings that, following cardiac damage, zTregs infiltrate the regenerating myocardium from the bloodstream, where mature Tregs are activated and expanded in number [59, 60, 61, 62]. Myocyte enhancer factor‐2 (Mef2) is one of the few signature cardiac transcription factors and the MEF2+ proliferating cardiomyocytes decrease in Treg‐depleted injury‐induced zebrafish heart, indicating a clear role of zTreg in cardiac regeneration [40, 63]. As a repercussion to cardiac injury, several cardiomyocyte mitogens namely the neuregulin 1 (Nrg1), insulin‐like growth factor 2a (Igf2a), insulin‐like growth factor 2b (Igf2b), and platelet‐derived growth factor subunit B (Pdgfb) are secreted from zTreg. Among these mitogens, a conspicuous up‐regulation of n rg1 is observed in the regenerating zebrafish heart. NRG1 signalling is reported to induce cardiomyocyte proliferation in both zebrafish and mammals, and the administration of human NRG1 can rescue cardiomyocyte proliferation in the injury‐induced Treg‐depleted heart of zebrafish [40].
Moreover, zTreg has been proved to be effective beyond its immunosuppressive role to facilitate regeneration in an organ‐specific manner. These cells are largely absent in uninjured organs, but rapidly migrate to the site of injury during 3–7 days post‐injury and promote the proliferation of regeneration precursor cells in the injured organs by producing tissue‐specific regenerative factors, such as Ntf3, for the spinal cord, and include Nrg1 for the heart and Igf1 for the retina [40] (Figure 1). Similar to the regeneration competent neonate mice, amphiregulin (Areg) is also another factor produced by zTreg, but in a non‐tissue‐specific manner [15, 18, 59]. It has also been found that the proregenerative role played by the zTreg is independent of its classical immunosuppressive function [64]. Improved zTreg recruitment has been observed in zebrafish following tail amputation after treating it with a dopamine agonist and this indicates the importance of dopaminergic signaling in the regulation of zTre g recruitment [65]. In the following sections, we discuss the tissue‐specific roles for zTregs in organ regeneration that can open a new vista of Treg cell‐mediated regenerative therapies in humans.
FIGURE 1.
Injury‐induced proregenerative responses of zebrafish regulatory T cells (zTregs) in various organs. (A) Spinal cord – recruitment of zTregs after spinal cord injury and secretion of neurotrophin‐3 (Ntf3), which facilitates proliferation of neural progenitors for successful spinal cord regeneration. (B) Retina – recruitment of zTregs after retinal injury and secretion of insulin‐like growth factor 1 (Igf1), which facilitates proliferation of Müller glia for successful retinal regeneration. (C) Heart – recruitment of zTregs after cardiac injury and secretion of neuregulin 1 (Nrg1), which facilitates the proliferation of cardiomyocytes for successful cardiac regeneration.
ZEBRAFISH AS A MODEL FOR REGULATORY T CELL BIOLOGY: WHAT WE DON’T KNOW
Evidence suggests that zTregs perform an evolutionary and universal involvement in maintaining homeostasis and regeneration of different tissues by generating growth factors that selectively boost the regeneration of tissue‐specific cell types in zebrafish. By controlling stem cell proliferation and differentiation in some adult tissues, mouse Tregs also can affect regeneration. Despite having a powerful immunomodulatory impact, Tregs are insufficient to induce regeneration in poor regenerative tissues such as the heart and central nervous system in mammals [30, 37, 66]. Unexpectedly, zebrafish deficient in Tregs or FoxP3 function do not acquire the same fatal autoimmunity condition as mice lacking the Treg function [40]. Possible redundancy of FoxP3b, which is not typically expressed in zTregs, might explain this phenotypical difference [39]. The mild inflammatory response reported in Treg‐deficient zebrafish may indicate that immunological responses are slowed in aquatic species [67]. Mammalian Tregs may have lost or have restricted proregenerative potential at the expense of acquiring a powerful immunosuppressive ability to harness a quick and strong inflammatory response that has developed in terrestrial animals to heal wounds [68]. Currently a number of transgenic lines of zebrafish are available, and these have further dissected out the Treg cell functions. In the damaged spinal cord of Foxp3a:green fluorescent protein (GFP) reporter zebrafish, GFP+ cells were found near proliferating neural progenitor cells during spinal cord regeneration [40]. Similar results were found in cardiac regeneration, further signifying the role of zTreg in organ regeneration in zebrafish which can only be accomplished when inflammation is restrained.
The inflammatory immune response is maintained by a variety of chemical mediators such as components of complements, vasoactive compounds, lipid mediators, cytokines, chemokines and proteolytic enzymes derived from plasma, immune cells or injured tissue niche. The same machinery has also been significantly developed in zebrafish, with the discovery of similar inflammatory mediators and receptors causing inflammatory responses by inflammasome activation. With the advent of zTreg, zebrafish is believed to be a future model for a clearer understanding of the complex mechanisms implicated in acute and chronic inflammatory diseases [69, 70]. The use of polyclonal Tregs can potentially suppress protective immunity against tumors and infectious diseases by transferring a large number of Tregs of broad undefined specificity. Thus, developing antigen‐specific Treg therapy will probably provide a more effective and safer alternative. Thus, Treg therapy is in recent focus to treat autoimmune diseases – including type 1 diabetes, rheumatoid arthritis, inflammatory bowel disease and graft‐versus‐host disease that often occur after bone marrow transplantation, organ transplant rejection and potentially to treat non‐immune diseases, such as heart disease and type 2 diabetes, Alzheimer’s disease and Parkinson’s disease [71]. According to this perspective, zTregs would be a new tool to move forward with the advancement of future Treg therapies.
zTregs are critical for complex tissue regeneration and have a remarkable ability to release tissue‐specific factors tailored to the tissue‐specific progenitors [40]. An interesting recent in vivo screening study identified novel compounds that potentially recruit zTreg to the injury niche and are implicated in tissue regeneration [65]. Investigating the zTreg population with proregenerative tissue‐specific growth factor secretory capacity using the single‐cell sequencing method will be a future tool to develop advanced Treg‐specific therapies for complex tissue regeneration and diseases. Thus, harnessing the Treg numbers and functions in injured or lost tissues by enhancing and/or promoting their proregenerative function in an injured niche may be a significant step in decoding the regenerative potentials in complex tissues of humans which lack regenerative potency.
DISCUSSION AND FUTURE PERSPECTIVES
Zebrafish have largely been used as a model for studying developmental processes. It has now emerged as an extremely important system for modeling human diseases. It is a smart system similar to those of mammalian models. Moreover, the whole‐genome duplication event and subfunction specialization of gene duplicates lead to a more intricate relationship among the components implicated within the response and, as a consequence, within the inflammatory response. Recent discoveries of subsets of T cells such as Tregs and their specific functions in several regeneration competent tissue niches have opened up immense possibilities to understand human diseases where Tregs might be implicated more clearly. This model offers real‐time imaging, and therefore the use of the full animal is an excellent tool to visualize the in vivo interaction of a pathogen within the system. Also, the genomic responses of adult zebrafish tissues can effectively reproduce the mammalian inflammatory process induced by acute endotoxin stress. Immune response and signaling have been well preserved all the way through evolution and mammal and zebrafish genomic responses after lipopolysaccharide (LPS) stimulation are highly correlated. In order to maintain homeostasis and regenerate various tissues, zTregs produce growth factors that selectively stimulate the regeneration of tissue‐specific cell types. The extraordinary ability of zebrafish to regenerate numerous organs suggests that studying zTreg activity in additional regeneration situations and clarifying the mechanism for proregenerative zTreg development may provide insights into how human Tregs may be specifically targeted to aid regeneration of damaged tissues. Therefore, zebrafish would become a promising and potent futuristic model to review the fundamental mechanisms of Treg biology, inflammation and regeneration and to model human inflammatory, autoimmune diseases to harness immune cell‐based therapies targeting Treg.
CONFLICTS OF INTEREST
The authors state no conflicts of interest.
AUTHOR CONTRIBUTIONS
S.P.H. conceptualized and designed the manuscript. SG., S.A. and S.P.H. wrote the manuscript and prepared the figure.
ACKNOWLEDGEMENTS
We thank Professor Sukla Ghosh and Mr Sayan Bhattacharya for critically reading the manuscript and the Department of Biotechnology (DBT), Government of India and Council of Scientific and Industrial Research (CSIR), Government of India for their support to S.P.H. and S.G., respectively. S.P.H. is a recipient of the Ramalingaswami Fellowship Award from the Department of Biotechnology, Government of India (BT/HRD/35/02/2006). S.G. is a recipient of the Junior Research Fellowship (JRF) award [09/028(1145)/2020‐EMR‐I] from the Council of Scientific and Industrial Research (CSIR), Government of India.
Gupta S, Adhikary S, Hui SP. Decoding the proregenerative competence of regulatory T cells through complex tissue regeneration in zebrafish. Clin Exp Immunol. 2021;206:344–353. 10.1111/cei.13661
DATA AVAILABILITY STATEMENT
Not applicable.
REFERENCES
- 1. Sabarish R, Rao SR, Lavu V. Natural T regulatory cells (n Treg) in the peripheral blood of healthy subjects and subjects with chronic periodontitis – a pilot study. J Clin Diagn Res. 2016;10:ZC36–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Fort MM, Narayanan PK. Manipulation of regulatory T‐cell function by immunomodulators: a boon or a curse? Toxicol Sci. 2010;117:253–62. [DOI] [PubMed] [Google Scholar]
- 3. Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol. 2000;12:676–83. [DOI] [PubMed] [Google Scholar]
- 4. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol. 2003;3:253–7. [DOI] [PubMed] [Google Scholar]
- 5. Faria AMC, Weiner HL. Oral tolerance. Immunol Rev. 2005;206:232–59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Mohr A, Atif M, Balderas R, Gorochov G, Miyara M. The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases. Clin Exp Immunol. 2019;197:24–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003;4:330–6. [DOI] [PubMed] [Google Scholar]
- 8. Bending D, Ono M. From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics. Clin Exp Immunol. 2019;197:14–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Josefowicz SZ, Lu L‐F, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. van der Vliet HJJ, Nieuwenhuis EE. IPEX as a result of mutations in FOXP3. Clin Dev Immunol. 2007;2007:89017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of Treg‐mediated T cell suppression. Front Immunol. 2012;3:51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Attias M, Al‐Aubodah T, Piccirillo CA. Mechanisms of human FoxP3+ Treg cell development and function in health and disease. Clin Exp Immunol. 2019;197:36–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity. 2004;21:589–601. [DOI] [PubMed] [Google Scholar]
- 14. Cederbom L, Hall H, Ivars F. CD4+CD25+ regulatory T cells down‐regulate co‐stimulatory molecules on antigen‐presenting cells. Eur J Immunol. 2000;30:1538–43. [DOI] [PubMed] [Google Scholar]
- 15. Arpaia N, Green J, Moltedo B, Arvey A, Hemmers S, Yuan S, et al. A distinct function of regulatory T cells in tissue protection. Cell. 2015;162:1078–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Burzyn D, Benoist C, Mathis D. Regulatory T cells in nonlymphoid tissues. Nat Immunol. 2013;14:1007–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. D’Alessio FR, Tsushima K, Aggarwal NR, West EE, Willett MH, Britos MF, et al. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest. 2009;119:2898–913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Burzyn D, Kuswanto W, Kolodin D, Shadrach J, Cerletti M, Jang Y, et al. A special population of regulatory T cells potentiates muscle repair. Cell. 2013;155:1282–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Castiglioni A, Corna G, Rigamonti E, Basso V, Vezzoli M, Monno A, et al. FOXP3+ T cells recruited to sites of sterile skeletal muscle injury regulate the fate of satellite cells and guide effective tissue regeneration. PLoS ONE. 2015;10:e0128094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Nosbaum A, Prevel N, Truong H‐A, Mehta P, Ettinger M, Scharschmidt TC, et al. Cutting edge: regulatory T cells facilitate cutaneous wound healing. J Immunol. 2016;196:2010–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Ali N, Zirak B, Rodriguez RS, Pauli ML, Truong H‐A, Lai K, et al. Regulatory T cells in skin facilitate epithelial stem cell differentiation. Cell. 2017;169:1119–1129.e11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kasheta M, Painter CA, Moore FE, Lobbardi R, Bryll A, Freiman E, et al. Identification and characterization of T reg‐like cells in zebrafish. J Exp Med. 2017;214:3519–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Lewkowicz N, Klink M, Mycko MP, Lewkowicz P. Neutrophil–CD4+CD25+ T regulatory cell interactions: a possible new mechanism of infectious tolerance. Immunobiology. 2013;218:455–64. [DOI] [PubMed] [Google Scholar]
- 24. Taams LS, van Amelsfort JMR, Tiemessen MM, Jacobs KMG, de Jong EC, Akbar AN, et al. Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol. 2005;66:222–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory cytokine IL‐35 contributes to regulatory T‐cell function. Nature. 2007;450:566–9. [DOI] [PubMed] [Google Scholar]
- 26. Hawrylowicz CM, O’Garra A. Potential role of interleukin‐10‐secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 2005;5:271–83. [DOI] [PubMed] [Google Scholar]
- 27. Kuswanto W, Burzyn D, Panduro M, Wang KK, Jang YC, Wagers AJ, et al. Poor repair of skeletal muscle in aging mice reflects a defect in local, interleukin‐33‐dependent accumulation of regulatory T cells. Immunity. 2016;44:355–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Li J, Tan J, Martino MM, Lui KO. Regulatory T‐cells: potential regulator of tissue repair and regeneration. Front Immunol. 2018;9:585. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Xia NI, Jiao J, Tang T‐T, Lv B‐J, Lu Y‐Z, Wang K‐J, et al. Activated regulatory T‐cells attenuate myocardial ischaemia/reperfusion injury through a CD39‐dependent mechanism. Clin Sci. 2015;128:679–93. [DOI] [PubMed] [Google Scholar]
- 30. Weirather J, Hofmann UDW, Beyersdorf N, Ramos GC, Vogel B, Frey A, et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. 2014;115:55–67. [DOI] [PubMed] [Google Scholar]
- 31. Dobaczewski M, Xia Y, Bujak M, Gonzalez‐Quesada C, Frangogiannis NG. CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol. 2010;176:2177–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Mock JR, Garibaldi BT, Aggarwal NR, Jenkins J, Limjunyawong N, Singer BD, et al. Foxp3+ regulatory T cells promote lung epithelial proliferation. Mucosal Immunol. 2014;7:1440–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Garibaldi BT, D’Alessio FR, Mock JR, Files DC, Chau E, Eto Y, et al. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol. 2013;48:35–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Glowacki AJ, Yoshizawa S, Jhunjhunwala S, Vieira AE, Garlet GP, Sfeir C, et al. Prevention of inflammation‐mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci USA. 2013;110:18525–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J. The glia‐derived alarmin IL‐33 orchestrates the immune response and promotes recovery following CNS injury. Neuron. 2015;85:703–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Dombrowski Y, O'Hagan T, Dittmer M, Penalva R, Mayoral SR, Bankhead P, et al. Regulatory T cells promote myelin regeneration in the central nervous system. Nat Neurosci. 2017;20:674–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Raposo C, Graubardt N, Cohen M, Eitan C, London A, Berkutzki T, et al. CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles. J Neurosci. 2014;34:10141–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Quintana FJ, Iglesias AH, Farez MF, Caccamo M, Burns EJ, Kassam N, et al. Adaptive autoimmunity and Foxp3‐based immunoregulation in zebrafish. PLoS ONE. 2010;5:e9478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Sugimoto K, Hui SP, Sheng DZ, Nakayama M, Kikuchi K. Zebrafish FOXP3 is required for the maintenance of immune tolerance. Dev Comp Immunol. 2017;73:156–62. [DOI] [PubMed] [Google Scholar]
- 40. Hui SP, Sheng DZ, Sugimoto K, Gonzalez‐Rajal A, Nakagawa S, Hesselson D, et al. Zebrafish regulatory T cells mediate organ‐specific regenerative programs. Dev Cell. 2017;43:659–672.e5. [DOI] [PubMed] [Google Scholar]
- 41. Goldshmit Y, Sztal TE, Jusuf PR, Hall TE, Nguyen‐Chi M, Currie PD. FGF‐dependent glial cell bridges facilitate spinal cord regeneration in zebrafish. J Neurosci. 2012;32:7477–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Reimer MM, Sorensen I, Kuscha V, Frank RE, Liu C, Becker CG, et al. Motor neuron regeneration in adult zebrafish. J Neurosci. 2008;28:8510–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Jopling C, Sleep E, Raya M, Martí M, Raya A, Izpisúa Belmonte JC. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature. 2010;464:606–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Kikuchi K, Holdway JE, Werdich AA, Anderson RM, Fang YI, Egnaczyk GF, et al. Primary contribution to zebrafish heart regeneration by GATA4(+) cardiomyocytes. Nature. 2010;464:601–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Fausett BV, Goldman D. A role for alpha1 tubulin‐expressing Müller glia in regeneration of the injured zebrafish retina. J Neurosci. 2006;26:6303–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Thummel R, Kassen SC, Montgomery JE, Enright JM, Hyde DR. Inhibition of Müller glial cell division blocks regeneration of the light‐damaged zebrafish retina. Dev Neurobiol. 2008;68:392–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Trede NS, Langenau DM, Traver D, Look AT, Zon LI. The use of zebrafish to understand immunity. Immunity. 2004;20:367–79. [DOI] [PubMed] [Google Scholar]
- 48. Godwin JW, Pinto AR, Rosenthal NA. Chasing the recipe for a pro‐regenerative immune system. Semin Cell Dev Biol. 2017;61:71–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Becker CG, Lieberoth BC, Morellini F, Feldner J, Becker T, Schachner M. L1.1 is involved in spinal cord regeneration in adult zebrafish. J Neurosci. 2004;24:7837–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Powell C, Grant AR, Cornblath E, Goldman D. Analysis of DNA methylation reveals a partial reprogramming of the Müller glia genome during retina regeneration. Proc Natl Acad Sci USA. 2013;110:19814–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Nelson CM, Ackerman KM, O’Hayer P, Bailey TJ, Gorsuch RA, Hyde DR. Tumor necrosis factor‐alpha is produced by dying retinal neurons and is required for Muller glia proliferation during zebrafish retinal regeneration. J Neurosci. 2013;33:6524–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Wan J, Ramachandran R, Goldman D. HB‐EGF is necessary and sufficient for Müller glia dedifferentiation and retina regeneration. Dev Cell. 2012;22:334–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Wan J, Zhao X‐F, Vojtek A, Goldman D. Retinal injury, growth factors, and cytokines converge on β‐catenin and pStat3 signaling to stimulate retina regeneration. Cell Rep. 2014;9:285–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Wan J, Goldman D. Retina regeneration in zebrafish. Curr Opin Genet Dev. 2016;40:41–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Zhao X‐F, Wan J, Powell C, Ramachandran R, Myers MG, Goldman D. Leptin and IL‐6 family cytokines synergize to stimulate Müller glia reprogramming and retina regeneration. Cell Rep. 2014;9:272–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Bernardos RL, Raymond PA. GFAP transgenic zebrafish. Gene Expr Patterns. 2006;6:1007–13. [DOI] [PubMed] [Google Scholar]
- 57. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science. 2002;298:2188–90. [DOI] [PubMed] [Google Scholar]
- 58. Raya A, Koth CM, Buscher D, Kawakami Y, Itoh T, Raya RM, et al. Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc Natl Acad Sci USA. 2003;100(Suppl 1):11889–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Kikuchi K. New function of zebrafish regulatory T cells in organ regeneration. Curr Opin Immunol. 2020;63:7–13. [DOI] [PubMed] [Google Scholar]
- 60. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic‐derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Weiss JM, Bilate AM, Gobert M, Ding YI, Curotto de Lafaille MA, Parkhurst CN, et al. Neuropilin 1 is expressed on thymus‐derived natural regulatory T cells, but not mucosa‐generated induced Foxp3+ T reg cells. J Exp Med. 2012;209:1723–42 S1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Yadav M, Louvet C, Davini D, Gardner JM, Martinez‐Llordella M, Bailey‐Bucktrout S, et al. Neuropilin‐1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo . J Exp Med. 2012;209:1713–22 S1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Desjardins CA, Naya FJ. The function of the MEF2 family of transcription factors in cardiac development, cardiogenomics, and direct reprogramming. J Cardiovasc Dev Dis. 2016;3:26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Jahn C, Weidinger G. Regulatory T cells know what is needed to regenerate. Dev Cell. 2017;43:651–2. [DOI] [PubMed] [Google Scholar]
- 65. Zwi SF, Choron C, Zheng D, Nguyen D, Zhang Y, Roshal C, et al. Pharmacological enhancement of regeneration‐dependent regulatory T cell recruitment in zebrafish. Int J Mol Sci. 2019;20:5189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Walsh JT, Zheng J, Smirnov I, Lorenz U, Tung K, Kipnis J. Regulatory T cells in central nervous system injury: a double‐edged sword. J Immunol. 2014;193:5013–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. Mescher AL, Neff AW. Regenerative capacity and the developing immune system. Adv Biochem Eng Biotechnol. 2005;93:39–66. [DOI] [PubMed] [Google Scholar]
- 68. Aurora AB, Olson EN. Immune modulation of stem cells and regeneration. Cell Stem Cell. 2014;15:14–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428–35. [DOI] [PubMed] [Google Scholar]
- 70. Forn‐Cuní G, Meijer AH, Varela M. Zebrafish in inflammasome research. Cells. 2019;8:901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Bluestone JA, Tang Q. Treg cells‐the next frontier of cell therapy. Science. 2018;362:154–5. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Not applicable.